Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Lincoln Pharmaceuticals Ltd
LINCOLN | NSE
625.55
INR6.00
0.97%
LINCOLN | NSE
Loading StockChartView...
About Lincoln Pharmaceuticals Ltd
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
05/06/2026
Close
625.55
Open
620.00
High
657.00
Low
620.00
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold anti-allergic and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins minerals and antioxidants; anti-bacterial anti-viral and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic anti-convulsant anti-depressant and anti-diabetic; cardiac anti-hypertensives and diuretic; and anti-diarrheal anti-spasmodic and laxative as well as dermatologist preparations gynecological products gastrointestinal rang otology products and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics. The company was incorporated in 1979 and is based in Ahmedabad India.
View LessLINCOLN | NSE
Risk
73.9
Sharpe
0.22
Luna's Score
54/100
Recommendation
Hold
Luna says (LINCOLN | NSE)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
95.7%1 month
73.9%3 months
56.6%6 months
53.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
13.55
Fwd. PE
-
Price to book
2.23
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
8.75
Ent. to rev.
2.05
PEG
-
Other Fundamentals
EBITDA
1.02B
MarketCap
12.53B
MarketCap(USD)
131.98M
Div. yield
0.27
Op. margin
13.25
Erngs. growth
24.60
Rev. growth
8.60
Ret. on equity
17.04
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
184.90
Range1M
184.90
Range3M
225.00
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.42
Price X volume
120.15M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.75 | 24.85 | Cheaper |
| Ent. to Revenue | 2.05 | 11.40 | Cheaper |
| PE Ratio | 13.55 | 51.36 | Cheaper |
| Price to Book | 2.23 | 6.83 | Cheaper |
| Dividend Yield | 0.27 | 0.52 | Poor |
| Std. Deviation (3M) | 56.56 | 42.17 | Riskier |
| Debt to Equity | 0.00 | 0.35 | Cheaper |
| Debt to Assets | 0.00 | 0.17 | Cheaper |
| Market Cap | 12.53B | 290.82B | Emerging |
